Business Context and Reporting Period
Park Ha Biological Technology Co., Ltd., a Cayman Islands exempted company, filed this Form 6-K for the month of December 2024. The filing reports the completion of the Company's initial public offering (IPO) and the commencement of trading on The Nasdaq Capital Market under the ticker symbol "PHH".
Key Financial Metrics
The filing details the terms of the IPO but does not provide historical revenue, profit, cash flow, margins, debt, or liquidity metrics for the Company.
- Shares Sold: 1,200,000 ordinary shares in the primary offering.
- Offering Price: $4.00 per share.
- Over-Allotment Option: Underwriters granted a 45-day option to purchase up to 180,000 additional shares.
- Underwriter: Dawson James Securities, Inc.
Material Changes
The primary material change reported is the transition from a private entity to a publicly traded company. Key milestones include:
- December 20, 2024: Registration Statement declared effective by the SEC.
- December 26, 2024: Underwriting agreement signed and IPO priced.
- December 27, 2024: Shares commenced trading on The Nasdaq Capital Market.
- December 30, 2024: IPO officially closed.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors beyond standard securities law disclaimers. It notes that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful prior to registration.
Investor Verification Checklist
- Verify the final number of shares sold, including any exercise of the 180,000 share over-allotment option.
- Confirm the total net proceeds received by the Company after underwriting discounts and commissions.
- Review the full Registration Statement on Form F-1 (File No. 333-281783) for detailed financial history and risk factors not included in this summary.
- Check the current trading volume and price of ticker "PHH" on The Nasdaq Capital Market.